S100A9 promotes metastasis in melanoma [7], and knockdown of S100A9 suppresses proliferation in glioma stem cells and inhibits the growth of xenograft tumors in vivo, suggesting an association between the tumorigenic potential of cancer stem cells and S100A9 upregulation [8]. This evidence concerns the gene S100A9 and central nervous system cancer.